Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 3/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 8/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 8/20 | 0.32 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 5/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8097954 | 0.88 | MAPK1 (0.33) | PIK3CDMAPK1PIK3CAMAP4K1CA12 | |
| SCHEMBL8093661 | 0.87 | PIK3CA (0.42) | NAMPTPIK3CDPIK3CAMTOR | |
| SCHEMBL8098657 | 0.85 | MAPT (0.37) | NAMPTPIK3CDROCK2PIK3CACA12 | |
| SCHEMBL8098658 | 0.85 | MAPT (0.37) | NAMPTPIK3CDROCK2PIK3CACA12 | |
| SCHEMBL8091937 | 0.84 | CA12 (0.39) | PIK3CDMAPK1ROCK2PIK3CAMAP4K1 | |
| SCHEMBL8091845 | 0.83 | PIK3CA (0.38) | NAMPTPIK3CDPIK3CACA12CA1 | |
| SCHEMBL8092462 | 0.83 | PIK3CA (0.38) | NAMPTPIK3CDPIK3CACA12CA1 | |
| SCHEMBL4208676 | 0.83 | PIK3CA (0.51) | PIK3CDPIK3CAMTOR | |
| SCHEMBL4213926 | 0.83 | PIK3CA (0.51) | PIK3CDPIK3CAMTOR | |
| SCHEMBL8089094 | 0.82 | PIK3CD (0.43) | PIK3CDROCK2PIK3CACA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009007748-A2 | TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | ASTRAZENECA AB (SE) | 2009-01-15 | — | — | WO | disclosed |